Internal Medicine, Nephrology · Houston, TX
NPI
1740262013
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2517 Dorrington St
Houston, TX, 77030
Phone (713) 383-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
857 services
Medicare patients, 2024
114
Average age 72
Drug cost, 2024
$104K
1,068 prescriptions
Company payments, 2025
$1,416
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bernardino F Abaya was code 99232 (hospital e&m - subsequent), 358 times for 75 patients. In total Bernardino F Abaya billed 857 services in 18 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 358 | 75 | $62.76 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 124 | 38 | $94.52 | $12K |
| 90960 ESRD Related Services (not dialysis) | Office | 75 | 13 | $272.44 | $20K |
| 90935 Hemodialysis | Facility | 63 | 17 | $55.82 | $3,517 |
| 99214 Office E&M - Established | Office | 41 | 21 | $95.12 | $3,900 |
| 99215 Office E&M - Established | Office | 38 | 21 | $139.24 | $5,291 |
| 99223 Hospital E&M - Initial | Facility | 25 | 19 | $137.86 | $3,446 |
By year: 2022 $81K for 729 services; 2023 $75K for 735 services; 2024 $86K for 857 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bernardino F Abaya prescribed most often to Medicare patients was Nifedipine Er (Nifedipine), with 59 prescriptions and refills. In total Bernardino F Abaya wrote 1,068 Medicare prescriptions that cost $104K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nifedipine Er Nifedipine | 59 | 137 | 20 | $1,556 |
| Atorvastatin Calcium Generic | 58 | 144 | 15 | $549 |
| Amlodipine Besylate Generic | 46 | 118 | 14 | $229 |
| Prednisone Generic | 40 | 82 | Under 11 | $309 |
| Carvedilol Generic | 33 | 77 | 11 | $199 |
| Hydralazine Hcl Generic | 30 | 86 | 11 | $474 |
| Famotidine Generic | 30 | 58 | Under 11 | $408 |
| Bumetanide Generic | 28 | 32 | Under 11 | $384 |
| Gabapentin Generic | 23 | 45 | Under 11 | $595 |
| Clonidine Hcl Generic | 23 | 41 | Under 11 | $133 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $547 |
| Tamsulosin Hcl Generic | 21 | 55 | Under 11 | $410 |
| Metoprolol Tartrate Generic | 21 | 63 | Under 11 | $192 |
| Furosemide Generic | 20 | 38 | Under 11 | $91.31 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 20 | 20 | Under 11 | $626 |
Brand drugs: - claims; generic drugs: 954 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernardino F Abaya $1,416 ($1,416 in general payments such as food, travel and fees) from 10 companies. The largest payer was Travere Therapeutics, Inc. with $348.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 7 | $348 |
| Mallinckrodt Hospital Products Inc. | 5 | $226 |
| Ardelyx, Inc. ARDX | 7 | $204 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $161 |
| Amgen Inc. AMGN | 2 | $161 |
| Akebia Therapeutics Inc AKBA | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $83.87 |
| Calliditas Therapeutics US Inc. | 2 | $44.75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39.9 |
| Novo Nordisk Inc NVO | 1 | $24.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.